1. Home
  2. |Insights
  3. |Mining Law Monitor - Volume 20, Issue 2 - (Summer 2003)

Mining Law Monitor - Volume 20, Issue 2 - (Summer 2003)

Client Alert | less than 1 min read | 08.11.03

  • "Cuban Embargo May Hold Hidden Perils for Unwary Mining Companies," Co-Authors: Jeff Snyder and Jim Reed.
  • "Arguments Over NBCWA Article I Reach Apogee," Co-Authors: Tom Gies and Glenn Grant.
  • "New FCC Rules Affect Some Mine Radio Systems," Author: Bill Wallace.
  • "SMCRA Roundup," Co-Authors: Tim Means and Michael Klise.
  • "The Safe Explosives Act: Homeland Security Comes to the Mining Industry," Co-Authors: Tim Biddle and Ed Green.

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights